A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).
about
Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report
P2860
A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@ast
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@en
type
label
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@ast
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@en
prefLabel
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@ast
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@en
P2093
P2860
P1476
A multi-institution phase II s ...... iary tract cancer (KHBO 1002).
@en
P2093
Atsushi Miyamoto
Daisuke Sakai
Etsuro Hatano
Hiroaki Nagano
Hiroaki Terajima
Hiroaki Yanagimoto
Hisanori Shiomi
Hisashi Ikoma
Masashi Kanai
Satoru Seo
P2860
P2888
P304
P356
10.1007/S00280-014-2648-9
P577
2014-12-05T00:00:00Z
P6179
1018459101